ASND
Ascendis Pharma·NASDAQ
--
--(--)
--
--(--)
6.05 / 10
Outperform
Fund flow rating is good (7.8/10) with overall inflow ratio ~0.49 despite negative trend. Analyst consensus is bullish: one Strong Buy and one Buy, weighted rating 4.30. Money‑flow sentiment is positive, supporting a cautiously optimistic outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-16
InstitutionJefferies
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for ASND?
- ASND holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.05/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
